Skip to content
Open access

Transforming pediatric oncology in Ecuador through the Global Platform for Access to Childhood Cancer Medicines

Aug 2026 · Revista Panamericana De Salud Publica-pan American Journal of Public Health · Vol 50, pp. 1 · 0 citations · 1 references
Medicine

TL;DR

Implementation of the Global Platform in Ecuador has strengthened pediatric oncology and positioned it as a national health priority and demonstrated that collaborative governance, intersectoral coordination and political commitment can build sustainable capacity to deliver equitable childhood cancer care.

Abstract

ABSTRACT Background. Childhood cancer survival exceeds 80% in high-income countries but remains below 50% across much of Latin America. In Ecuador, limited access to diagnosis and essential medicines, and fragmented governance have hindered progress. In 2025, Ecuador became the first country in the Region of the Americas to implement the Global Platform for Access to Childhood Cancer Medicines, an initiative led by the World Health Organization (WHO) and St. Jude Children’s Research Hospital to ensure equitable access to quality medicines while strengthening health systems. Methods. Between 2023 and 2025, Ecuador’s Ministry of Public Health, the Pan American Health Organization (PAHO), WHO and St. Jude codesigned a participatory implementation plan. A national situational analysis guided the 2024–2026 roadmap and focused on governance, regulatory alignment, supply-chain optimization and workforce capacity. Key operational tools included medicine forecasting and quantification methodologies, developing standardized treatment protocols, and coordinating with the immunization program’s cold-chain infrastructure. Results. The initiative catalyzed the creation of the National Commission for Childhood and Adolescent Cancer, integration of all prioritized oncology medicines into the national formulary, and consensus in national treatment protocols. Strengthened logistics reduced delivery times for medicines to less than 96 hours, and chemotherapy management training established a foundation for continuing education. Ecuador became the first country in the Region to receive medicines for childhood cancer procured through the Global Platform. Conclusions. Implementation of the Global Platform in Ecuador has strengthened pediatric oncology and positioned it as a national health priority. By coupling medicine access with systemic reform, Ecuador has demonstrated that collaborative governance, intersectoral coordination and political commitment can build sustainable capacity to deliver equitable childhood cancer care.

Read PDF

Similar papers

Sep 2026

Best practices for implementing the WHO Model List of Essential Cancer Medicines: Chile, Kenya, and Thailand.

BACKGROUND Cancer is a leading global cause of death, with the burden rising fastest in low- and middle-income countries (LMICs). The WHO Model List of Essential Medicines for Cancer (EML-C) provides an evidence-based benchmark for prioritizing safe and cost-effective therapies for reaching Universal Health Coverage (U...

Veronica Vargas, R. Cortez, D. Kizub et al. · 0 citations
Review Open access Sep 2026

Financing and health system capacity for precision medicine in Asia: a six country landscape analysis

Abstract Background Precision medicine (PM) adoption is accelerating across Asia, but implementation remains uneven due to differences in financing, infrastructure, governance, and health-system readiness. Objectives To examine how six Asian countries (Singapore, South Korea, China, Malaysia, Thailand, and Indonesia) a...

A. L. Peh, Y. Teerawattananon, Jeanette Yuen et al. · 0 citations
Open access Sep 2026

CureAll Brasil: Strategic Agenda to Strengthen the National Health System and Equity in Childhood Cancer Care

Childhood cancer is an important marker of the performance of health systems, given its complexity and dependence of timely diagnosis and continuous care. This editorial discusses the strategic role of CureAll Framework of the World Health Organization as a model to strengthen the health systems and reduce the inequali...

Lopes-Júnior Luís Carlos · 0 citations
Review Open access Sep 2026

Landscape of cancer genomics and precision oncology in Japan, South Korea, China, and Australia

Summary Precision oncology has expanded rapidly across the Asia–Pacific region, yet implementation remains heterogeneous because of differences in health-system organisation, reimbursement, molecular tumour board infrastructure, workforce capacity, and data integration. This structured narrative review with expert cons...

H. Bando, H. Okayama, Yoon Jung Chang et al. · 1 citation
Review Open access Sep 2026

Cancer care in Pakistan: a national survey of infrastructure, diagnostic capacity, therapeutic access, and workforce perspectives

Pakistan, a lower-middle-income country of some 241 million people, faces a rising cancer burden — an estimated 185,748 new cancer cases and 118,631 cancer deaths in 2022 — that is served by a heterogeneous and largely uncoordinated mix of public, private for-profit, philanthropic, and Atomic Energy Commission cancer f...

Asim Jamal Shaikh, Fatima Shaukat, Asif Sarwar et al. · 0 citations
Open access Sep 2026

Global uptake of essential cancer medicines with and without complex genomic diagnostics: a retrospective observational study.

BACKGROUND New cancer medicines increasingly depend on molecular testing, from low-cost immunohistochemistry to expensive genomic diagnostics. The WHO Model List of Essential Medicines (EML) guides access to priority medicines. We aimed to analyse uptake trends for essential cancer medicines in 71 countries and two wor...

Kerstin N. Vokinger, S. Hediger, R. Casolino et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.